| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |